[go: up one dir, main page]

WO2025080075A1 - Composition pour le traitement et la prévention de la rhinite et son procédé de préparation - Google Patents

Composition pour le traitement et la prévention de la rhinite et son procédé de préparation Download PDF

Info

Publication number
WO2025080075A1
WO2025080075A1 PCT/KR2024/096263 KR2024096263W WO2025080075A1 WO 2025080075 A1 WO2025080075 A1 WO 2025080075A1 KR 2024096263 W KR2024096263 W KR 2024096263W WO 2025080075 A1 WO2025080075 A1 WO 2025080075A1
Authority
WO
WIPO (PCT)
Prior art keywords
rhinitis
composition
minerals
nasal
mineral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/KR2024/096263
Other languages
English (en)
Korean (ko)
Inventor
김천균
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2025080075A1 publication Critical patent/WO2025080075A1/fr
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Definitions

  • the present invention relates to a composition for treating and preventing rhinitis and a method for producing the same, and more particularly, to a composition for treating and preventing rhinitis and a method for producing the same, which cures nasal diseases without side effects by removing various harmful components that accumulate in nasal cells and cause various nasal diseases, including rhinitis, through ionic bonds and covalent bonds.
  • the nose is divided into the respiratory part, which is responsible for ‘breathing’, and the olfactory part, which is responsible for ‘smell’. Most of this is the respiratory part, and the mucous membrane of this respiratory part is covered with very fine ‘ciliary cells’. These cilia are not hairs, but rather a type of cell.
  • the cilia in the nasal mucus layer serve as an important defense mechanism that protects our body by constantly removing dust and bacteria that enter from the outside.
  • this mucus transport system has the ability to transport particles as small as 0.5 mm in diameter, when this function is performed normally, even ‘bacteria’ can hardly penetrate the mucosal cells.
  • the nasal mucosa When harmful substances accumulate in the nasal cells and cause a runny nose, the nasal mucosa swells or dries, preventing smooth airflow in the nose. This leads to the decay of the nasal mucus, which in turn becomes a breeding ground for various bacteria and viruses. Then, the ciliary cells, which play an important role in the ‘nasal defense mechanism’ against foreign substances, also fail to function properly, greatly reducing the respiratory system’s self-purification ability.
  • fine dust, various foreign substances, and bacteria that nasal hairs cannot filter out combine with the mucus secreted in the nose and are discharged from the body in the form of boogers or ‘runny nose’, or harmful dust or bacteria caught in the mucus layer (cilium) in the nose pass into the pharynx, larynx, and esophagus and are sterilized in the stomach where ‘strong gastric acid’ is secreted.
  • rhinitis which allows a large amount of toxic substances to enter the body, acts as the source of all diseases. If rhinitis is the cause of all diseases such as cancer, asthma, dementia, atopy, and high blood pressure, most people will tilt their heads in confusion, thinking, “Could all these diseases be caused by a simple rhinitis?”
  • the modern atmosphere contains a large amount of various harmful substances (or toxic substances) such as carcinogens and pesticides.
  • various harmful substances or toxic substances
  • the food that modern people eat is full of various harmful substances such as pesticides and toxic substances that were almost non-existent even 100 years ago.
  • Pesticides which are toxic substances sprayed on farmland, do not only contaminate farmland with toxic substances. Pesticides sprayed on farmland eventually evaporate with water, causing pesticides to spread throughout the air. In addition, pesticides sprayed on farmland go down into the ground, turning groundwater into highly toxic pesticide groundwater.
  • VOCs volatile organic compounds
  • new house syndrome various abnormal symptoms that occur when moving into a new house are called ‘new house syndrome’, and these are all phenomena that occur when the indoor air is polluted by the evaporation of volatile organic compounds.
  • the human body consists of 100,000,000,000,000 cells, and each cell has 3,000 mitochondria and 2,000 liposome. It will take at least 20 to 30 years at the current rate of scientific and technological advancement to develop ultra-precision science and technology that can examine or diagnose whether the mitochondria in these cells have all died and only 100 remain, causing itchiness and pain, whether 10 toxic elements have attached themselves to them and irritated the cells in the nose, causing a stuffy nose and excessive runny nose, or whether 10,000 of them have attached themselves to them, or whether the pain is caused by some other toxic element attached to the cells.
  • rhinitis is a typical incurable disease that cannot be cured with medication or surgery.
  • Rhinitis is a serious disease that is the cause of all diseases.
  • the present invention aims to provide a composition for treating and preventing rhinitis and a method for producing the same, which is very safe for the human body and can be very usefully used as a therapeutic agent for not only completely curing rhinitis but also treating and preventing various nasal diseases.
  • the present invention aims to provide a composition for treating and preventing rhinitis, which can increase the therapeutic effect of curing rhinitis and various nasal diseases and reduce unexpected side effects by mixing germanium (Ge), an element that emits far-infrared rays, into the effective ingredient, and a method for producing the same.
  • germanium Ge
  • the purpose of the present invention is to provide a composition for treating and preventing rhinitis, which can supply necessary nutrients to human cells without any damage by mixing an appropriate amount of organic acid with an effective ingredient and adjusting the pH to 5 to 10 suitable for nasal mucosal cells, and a method for producing the same.
  • the present invention aims to provide a composition for treating and preventing rhinitis, which can remarkably shorten the period of cure for rhinitis and nasal disease by making a mineral that has lost one or more electrons dissolve in purified water, water, beverages or oils at a concentration of 10 -12 to 10 -9 m, thereby allowing rapid absorption into cells, and a method for producing the same.
  • a composition for treating and preventing rhinitis comprises germanium (Ge), silver (Ag), iridium (Ir), nickel (Ni), palladium (Pd), tantalum (Ta), antimony (Sb), zinc (Zn), indium (In), boron (B), astatine (At), thallium (Tl), magnesium carbonate (MgCO 3 ), tin (Sn), iron (Fe), calcium sulfur (CaS), molybdenum (Mo), chromium (Cr), sodium (Na), tungsten (W), gallium (Ga), strontium (Sr), potassium (K), beryllium (Be), barium (Ba), magnesium (Mg), scandium (Sc), yttrium (Y), calcium (Ca), titanium (Ti), vanadium (V), hafnium (Hf), bromine (Br), zirconium (Zr), copper (Cu), manganese (Mn), rubidium
  • the active ingredient is mixed with germanium (Ge).
  • the amount of germanium (Ge) is 0.05 to 2 wt% of the amount of mineral.
  • the active ingredient is mixed with organic acid to adjust the pH to 5 to 10.
  • the active ingredient is soluble in purified water, water, beverages or oils at 10 -12 to 10 -9 m.
  • the active ingredient is mixed with organic acid to adjust the pH to 5 to 10.
  • the content of minerals is 0.1 to 50 wt% with respect to the total weight of the composition.
  • At least one of the following active ingredients is added: a nutrient, a hardener, a solubilizer, an oil, a preservative, a thickener, a refreshing agent, or a fragrance.
  • a composition for treating and preventing rhinitis comprises germanium (Ge), silver (Ag), iridium (Ir), nickel (Ni), palladium (Pd), tantalum (Ta), antimony (Sb), zinc (Zn), indium (In), boron (B), astatine (At), thallium (Tl), magnesium carbonate (MgCO 3 ), tin (Sn), iron (Fe), calcium sulfur (CaS), molybdenum (Mo), chromium (Cr), sodium (Na), tungsten (W), gallium (Ga), strontium (Sr), potassium (K), beryllium (Be), barium (Ba), magnesium (Mg), scandium (Sc), yttrium (Y), calcium (Ca), titanium (Ti), vanadium (V), hafnium (Hf), bromine (Br), zirconium (Zr), copper (Cu), manganese (Mn), rubidium
  • a mineral selected from technetium (Tc), platinum (Pt), niobium (Nb), gold (Au), phosphate (Pi), rhenium (Re), ruthenium (Ru), cobalt (Co), zinc oxide (ZnO), aluminum (Al), selenium (Se), bismuth (Bi), phosphorus (P), rhodium (Rh), silicon (Si), iodine (I), tellurium (Te), sulfur (S), lithium (Li), osmium (Os), magnesium hydroxide (Mg(OH) 2 ), and cesium (Cs); and a second step of mixing the mineral having lost at least one electron and purified water in a weight ratio of 1:1 to 1:1,000 to obtain a strongly alkaline composition, wherein the number of minerals is at least five.
  • a step of mixing an organic acid into the strong alkaline composition to adjust the pH to 5 to 10 is further included.
  • compositions for treating and preventing rhinitis and a method for producing the same which is very safe for the human body and can be very usefully used as a therapeutic agent for not only completely curing rhinitis but also treating and preventing various nasal diseases.
  • germanium an element that emits far-infrared rays, is mixed into the effective ingredient to increase the therapeutic effect on curing rhinitis and various nasal diseases, and reduce unexpected side effects.
  • a mineral that has lost one or more electrons is made to dissolve in purified water, water, beverages or oils at a concentration of 10 -12 to 10 -9 m, so that absorption into cells is accelerated, thereby accelerating the cure of rhinitis and the treatment period for nasal congestion.
  • Figure 1 is a flow chart of a method for manufacturing a composition for treating and preventing rhinitis according to one embodiment of the present invention.
  • FIG. 2 is a test performance report measuring the reduction in the size of water molecule clusters by adding 1:100 wt% of a mineral that has lost at least one electron and purified water according to one embodiment of the present invention.
  • Figure 3 is a schematic diagram illustrating ionic bonding according to one embodiment of the present invention.
  • Figure 4 is a schematic diagram illustrating a covalent bond according to one embodiment of the present invention.
  • magnesium (Mg) treats muscle weakness
  • iron (Fe) treats anemia
  • zinc (Zn) treats acne
  • calcium (Ca) treats osteoporosis.
  • Mg muscle weakness
  • Fe iron
  • Zn zinc
  • Ca calcium
  • minerals are essential nutrients that are used for the prevention and treatment of specific diseases.
  • Minerals which are the five major nutrients with such amazing efficacy in the prevention and treatment of various diseases, are representative nutrients that are not easily digested and absorbed as metal elements.
  • the clusters of water or oil are reduced to a size that can be absorbed by skin cells in the nose, so even if the composition of the present invention is simply sprayed inside the nose, it is absorbed into the nasal cells and removes harmful substances accumulated in the nasal cells through ionic and covalent bonds.
  • This physical mechanism that simply cures rhinitis and treats various nasal diseases without any side effects is that when iron ore is put in a furnace and heated to a high temperature of 1250°C or higher, the iron (Fe) element becomes an unstable element that loses at least one electron. In physics, this is explained as the properties of a metal substance changing when heat of 1250°C is applied to it.
  • a high temperature of 900°C (preferably 1250°C) or higher must be applied so that all the minerals lose at least one electron.
  • iron (Fe) is not close to other substances such as dirt in iron ore, so it does not form ionic or covalent bonds with them, but only forms ionic bonds with iron (Fe) that is close to it.
  • the iron that comes out in the furnace by sticking together (ionic bonds) is pig iron, and when this pig iron cools, it becomes a lump of pig iron.
  • iron is said to be rusted when it breaks off from the iron bond (iron lump) by combining with oxygen.
  • harmful substances which are the cause of rhinitis, are attached to the cells in the nose through ionic or covalent bonds with proteins and accumulated, are removed through ionic or covalent bonds with minerals that enter the cells in the nose, rhinitis is cured and various nasal diseases are also treated.
  • the type of mineral that binds with each type of the underlying substance that causes rhinitis and various nasal diseases is different, the type of mineral was included accordingly, and the amount of mineral was adjusted to a similar ratio to the amount of harmful substances accumulated in the nasal cells to implement a preventive agent that completely cures rhinitis and various nasal diseases.
  • Organic minerals are minerals that are excreted from the body even if they are used and left over, so they are organic minerals that have no side effects even if they are absorbed in large quantities by the body.
  • Inorganic minerals are minerals that exist in nature and are not combined with amino acids or proteins. If you consume a lot of these inorganic minerals, they are not combined with anything, so the ionic and covalent bonds are so strong that a large amount of them bind to the proteins of blood vessel cells before being delivered to the cells, causing not only arteriosclerosis, but also diseases such as gallstones or stones.
  • inorganic minerals are absorbed by plants and combined with amino acids or proteins to become plant components.
  • the minerals that are plant components created in this way are organic minerals, and humans consume these plants and use them as essential nutrients for the human body (such as human body components), and unlike inorganic minerals, organic minerals do not cause side effects to the human body even if consumed in large quantities.
  • the digestive power of the stomach acid and the acid in our intestines is good enough to make us lose at least one electron, so the mineral absorption rate is 60-80%.
  • the ability of the stomach acid and the acid in our intestines to lose electrons decreases, so the mineral absorption rate drops significantly to less than 30%.
  • each type of harmful substance has different minerals that bond ionicly or covalently depending on the characteristics of the substance
  • the type of mineral that binds to the nasal cells is also included according to the type of harmful substance that bonds ionicly or covalently with them.
  • the composition of the present invention contains at least five types of minerals that have lost electrons as an effective ingredient.
  • This composition contains various elements beneficial to the human body in addition to minerals that bind to various harmful substances that cause rhinitis, so it completely cures rhinitis without any side effects and is also excellent in preventing various nasal diseases.
  • This composition contains minerals that make harmful substances, which are the root cause of rhinitis and other nasal diseases, lose at least one electron with a stronger bond than the bond with proteins of body cells, and ionic or covalent bonds, thereby causing harmful substances, which are the root cause of rhinitis, to fall off from the proteins of nasal cells, thereby completely curing even severe rhinitis in a short period of time without any side effects.
  • the type and amount of minerals combined can be adjusted to an appropriate ratio to implement a composition for curing rhinitis and treating various nasal diseases.
  • the minerals contained in this composition are unstable minerals that have lost at least one electron, they are absorbed by more than 95% in the intestines and are therefore very effective in treating nasal diseases.
  • composition for treating and preventing rhinitis can be composed in various ways as follows.
  • a composition for treating and preventing rhinitis comprises germanium (Ge), silver (Ag), iridium (Ir), nickel (Ni), palladium (Pd), tantalum (Ta), antimony (Sb), zinc (Zn), indium (In), boron (B), astatine (At), thallium (Tl), magnesium carbonate (MgCO 3 ), tin (Sn), iron (Fe), calcium sulfur (CaS), molybdenum (Mo), chromium (Cr), sodium (Na), tungsten (W), gallium (Ga), strontium (Sr), potassium (K), beryllium (Be), barium (Ba), magnesium (Mg), scandium (Sc), yttrium (Y), calcium (Ca), titanium (Ti), vanadium (V), hafnium (Hf), bromine (Br), zirconium (Zr), copper (Cu), manganese (Mn), rubidium (Ge), germanium (Ge
  • Minerals that have lost one or more electrons can be made by mixing one or more minerals extracted from various minerals containing a large amount of inorganic minerals, as well as from bovine bones, foods, herbal medicines, seaweed, raw materials for burdock, and raw materials for cassia moss containing a large amount of organic minerals.
  • a high temperature of 1250°C or higher In order to create the minerals of this composition that cure rhinitis and treat and prevent various nasal diseases by making all minerals lose electrons, a high temperature of 1250°C or higher must be applied. In addition, the reason for applying a high temperature of 1250°C or higher to make all minerals lose at least one electron is to allow the minerals to be absorbed into the body's cells as much as possible and to completely remove impurities.
  • the reason why the number of minerals that have lost at least one electron is at least 5 is because it is difficult to remove harmful substances from the human body if there are less than 5 minerals.
  • the number of minerals that have lost at least one electron is at least 15.
  • this composition is very safe for the human body, it can be very usefully used as a treatment for not only curing rhinitis but also treating and preventing various nasal diseases.
  • a composition for treating and preventing rhinitis comprises germanium (Ge), silver (Ag), iridium (Ir), nickel (Ni), palladium (Pd), tantalum (Ta), antimony (Sb), zinc (Zn), indium (In), boron (B), astatine (At), thallium (Tl), magnesium carbonate (MgCO 3 ), tin (Sn), iron (Fe), calcium sulfur (CaS), molybdenum (Mo), chromium (Cr), sodium (Na), tungsten (W), gallium (Ga), strontium (Sr), potassium (K), beryllium (Be), barium (Ba), magnesium (Mg), scandium (Sc), yttrium (Y), calcium (Ca), titanium (Ti), vanadium (V), hafnium (Hf), bromine (Br), zirconium (Zr), copper (Cu), manganese (Mn), rubidium (Ge), germanium (Ge
  • Far infrared rays have a longer wavelength than visible light, so when they are irradiated on the human body, they have the characteristic of being converted into heat. Due to this characteristic of far infrared rays, when far infrared rays are irradiated on the organs of the body, including nasal cells, the light is converted into heat, which expands the blood vessels, increasing the blood supply to all tissues in the body and increasing the supply of oxygen and nutrients.
  • far infrared rays are widely used around us and are also used in the medical field for various disease treatments because they promote cellular metabolic activity, speed up the cure of rhinitis and various nasal diseases, and reduce the side effects of disease treatments.
  • Far infrared heat expands blood vessels and promotes blood circulation to relieve pain, and is used to treat conditions such as muscle relaxation, muscle pain, joint pain, tendonitis, sprains and post-sprain rehabilitation, and chronic pain management.
  • the heat of far infrared rays accelerates the healing rate of wounds and promotes the activation and restoration of nasal cells, which helps cure rhinitis and nasal congestion.
  • the far-infrared radiation component which has been revealed through experimental results from current research to have various disease treatment effects and reduce various side effects of disease treatment drugs, is made to lose at least one electron so that it can be well absorbed by nasal mucosal cells.
  • the amount of germanium (Ge), an element that emits far-infrared rays is set to 0.05 to 2 weight percent of the amount of minerals.
  • composition's effective ingredient germanium (Ge), which is an element that emits far-infrared rays, can increase the therapeutic effect of curing rhinitis and various nasal diseases and reduce unexpected side effects.
  • the effect is minimal, and even if the amount of germanium (Ge), an element that radiates far-infrared rays, exceeds 2% of the amount of minerals, the effect does not increase further.
  • the active ingredient may be added with at least one of a nutrient, a hardener, a solubilizer, an oil, a preservative, a thickener, a refreshing agent, or a fragrance.
  • a composition for treating and preventing rhinitis comprises germanium (Ge), silver (Ag), iridium (Ir), nickel (Ni), palladium (Pd), tantalum (Ta), antimony (Sb), zinc (Zn), indium (In), boron (B), astatine (At), thallium (Tl), magnesium carbonate (MgCO 3 ), tin (Sn), iron (Fe), calcium sulfur (CaS), molybdenum (Mo), chromium (Cr), sodium (Na), tungsten (W), gallium (Ga), strontium (Sr), potassium (K), beryllium (Be), barium (Ba), magnesium (Mg), scandium (Sc), yttrium (Y), calcium (Ca), titanium (Ti), vanadium (V), hafnium (Hf), bromine (Br), zirconium (Zr), copper (Cu), manganese (Mn), rubidium
  • the minerals that have lost one or more electrons which are the effective ingredients of this composition, are strongly alkaline with a pH of 12 or higher, so if used as is, nasal cells may be damaged. Therefore, in order to lower the pH with organic acid, if organic acid is added in the amount of minerals contained in this composition, the pH becomes neutral, and if organic acid is added in less than the mineral content, the pH becomes alkaline. And if organic acid is added in greater than the mineral content, the pH becomes acidic.
  • the present composition can supply necessary nutrients to human cells without any damage by adjusting the pH to 5 to 10, which is suitable for nasal mucosal cells, by mixing an appropriate amount of organic acid with the effective ingredient.
  • Organic acid refers to an organic compound that is acidic.
  • Organic acid is the counterpart to inorganic acid, and acids obtained from the mineral kingdom are called inorganic acids, while acids obtained from the plant and animal kingdom are called organic acids.
  • organic acids that exist in nature are carboxylic acids, such as acetic acid, oxalic acid, tartaric acid, and benzoic acid. Therefore, in classical literature, the term organic acid was sometimes used to mean the same thing as other names for carboxylic acids. However, among the organic acids that have been known since long ago, there are also non-carboxylic acids, such as uric acid, and now that many organic compounds are known, the term organic acid in a broad sense is a general term for all organic compounds that have acidity.
  • a composition for treating and preventing rhinitis comprises germanium (Ge), silver (Ag), iridium (Ir), nickel (Ni), palladium (Pd), tantalum (Ta), antimony (Sb), zinc (Zn), indium (In), boron (B), astatine (At), thallium (Tl), magnesium carbonate (MgCO 3 ), tin (Sn), iron (Fe), calcium sulfur (CaS), molybdenum (Mo), chromium (Cr), sodium (Na), tungsten (W), gallium (Ga), strontium (Sr), potassium (K), beryllium (Be), barium (Ba), magnesium (Mg), scandium (Sc), yttrium (Y), calcium (Ca), titanium (Ti), vanadium (V), hafnium (Hf), bromine (Br), zirconium (Zr), copper (Cu), manganese (Mn), rubidium
  • a composition for treating and preventing rhinitis comprises germanium (Ge), silver (Ag), iridium (Ir), nickel (Ni), palladium (Pd), tantalum (Ta), antimony (Sb), zinc (Zn), indium (In), boron (B), astatine (At), thallium (Tl), magnesium carbonate (MgCO 3 ), tin (Sn), iron (Fe), calcium sulfur (CaS), molybdenum (Mo), chromium (Cr), sodium (Na), tungsten (W), gallium (Ga), strontium (Sr), potassium (K), beryllium (Be), barium (Ba), magnesium (Mg), scandium (Sc), yttrium (Y), calcium (Ca), titanium (Ti), vanadium (V), hafnium (Hf), bromine (Br), zirconium (Zr), copper (Cu), manganese (Mn), rubidium
  • Minerals that have lost one or more electrons can be made to dissolve in purified water, water, beverages, or oils at 10 -12 to 10 -9 m and implemented. When dissolved at 10 -12 to 10 -9 m, they are absorbed in large quantities into the nasal mucosa, so the period of rhinitis cure and nasal congestion treatment is surprisingly fast.
  • a composition for treating and preventing rhinitis comprises germanium (Ge), silver (Ag), iridium (Ir), nickel (Ni), palladium (Pd), tantalum (Ta), antimony (Sb), zinc (Zn), indium (In), boron (B), astatine (At), thallium (Tl), magnesium carbonate (MgCO 3 ), tin (Sn), iron (Fe), calcium sulfur (CaS), molybdenum (Mo), chromium (Cr), sodium (Na), tungsten (W), gallium (Ga), strontium (Sr), potassium (K), beryllium (Be), barium (Ba), magnesium (Mg), scandium (Sc), yttrium (Y), calcium (Ca), titanium (Ti), vanadium (V), hafnium (Hf), bromine (Br), zirconium (Zr), copper (Cu), manganese (Mn), rubidium
  • germanium an element that emits far-infrared rays, and the fact that it is made of 10 -12 ⁇ 10 -9 m, it is as explained in 2) and 5) above, respectively.
  • a composition for treating and preventing rhinitis comprises germanium (Ge), silver (Ag), iridium (Ir), nickel (Ni), palladium (Pd), tantalum (Ta), antimony (Sb), zinc (Zn), indium (In), boron (B), astatine (At), thallium (Tl), magnesium carbonate (MgCO 3 ), tin (Sn), iron (Fe), calcium sulfur (CaS), molybdenum (Mo), chromium (Cr), sodium (Na), tungsten (W), gallium (Ga), strontium (Sr), potassium (K), beryllium (Be), barium (Ba), magnesium (Mg), scandium (Sc), yttrium (Y), calcium (Ca), titanium (Ti), vanadium (V), hafnium (Hf), bromine (Br), zirconium (Zr), copper (Cu), manganese (Mn), rubidium
  • a composition for treating and preventing rhinitis comprises germanium (Ge), silver (Ag), iridium (Ir), nickel (Ni), palladium (Pd), tantalum (Ta), antimony (Sb), zinc (Zn), indium (In), boron (B), astatine (At), thallium (Tl), magnesium carbonate (MgCO 3 ), tin (Sn), iron (Fe), calcium sulfur (CaS), molybdenum (Mo), chromium (Cr), sodium (Na), tungsten (W), gallium (Ga), strontium (Sr), potassium (K), beryllium (Be), barium (Ba), magnesium (Mg), scandium (Sc), yttrium (Y), calcium (Ca), titanium (Ti), vanadium (V), hafnium (Hf), bromine (Br), zirconium (Zr), copper (Cu), manganese (Mn), rubidium
  • the content of minerals may be 0.1 to 50 wt%.
  • the treatment and prevention effects of various nasal diseases including rhinitis cure are too minimal.
  • the mineral content exceeds 50 wt%, the treatment and prevention effects of various nasal diseases including rhinitis cure do not increase as the mineral content increases, making it ineffective, and stability in the formulation is not secured.
  • the content of minerals must be 0.1 to 50 wt% to obtain the effects of curing rhinitis and treating and preventing various nasal diseases, and as the content of minerals increases, the effects of curing rhinitis and treating and preventing various nasal diseases increase, making it efficient, and ensuring stability in the formulation.
  • FIG. 1 is a flow chart of a method for manufacturing a rhinitis-curing composition according to one embodiment of the present invention
  • FIG. 2 is a test performance report measuring a decrease in the size of water molecule groups (clusters) by adding a mineral that has lost at least one electron and purified water in a ratio of 1:100 wt% according to one embodiment of the present invention.
  • a method for preparing a composition for treating and preventing rhinitis may include S100 to S400.
  • the various harmful substances that accumulate in nasal cells and cause rhinitis and various nasal diseases have different mineral components that are ionic or covalently bonded depending on the characteristics of each substance. Therefore, the various harmful substances and various toxic substances accumulated in nasal cells have different minerals that are ionic or covalently bonded depending on each component, so it may be necessary to prepare various minerals that are suitable for each component before performing S100.
  • a mineral that has lost one or more electrons can be mixed with purified water in a weight ratio of 1:1, the stability of such a composition is low, and it is very ineffective because its rhinitis treatment effect is similar to that of a composition mixed in a weight ratio of 1:50 to 1:100.
  • a mineral that has lost at least one electron can be mixed in a weight ratio of 1:1,000 with purified water, but it is very ineffective because the rhinitis cure period is greatly increased.
  • the organic acid is mixed in a ratio of 3:1 to 3:100 in a strong alkaline composition having a pH of 12 or higher to adjust the pH to 5 to 10 (S300).
  • the organic acid is mixed to lower the pH. If the organic acid is added in the amount of the mineral content contained in the composition, the pH becomes neutral, and if the organic acid is added in excess of the mineral content, the pH becomes acidic. That is, if the pH is 7, it is neutral, if it is 7 or higher, it is alkaline, and if it is 7 or lower, it is acidic.
  • Figure 3 is a schematic diagram illustrating ionic bonding according to one embodiment of the present invention.
  • an ionic bond refers to a method of bonding by giving and receiving electrons between atoms.
  • Sodium (Na) has only one electron in its outermost shell
  • chlorine (Cl) has seven electrons in its outermost shell. According to the octet rule, atoms tend to maintain the number of electrons in their outermost shell at eight.
  • sodium (Na) and chlorine (Cl) approach each other, sodium (Na) tries to donate one of its remaining electrons to chlorine (Cl), and chlorine (Cl) tries to receive one of its missing electrons from sodium (Na).
  • Figure 4 is a schematic diagram illustrating a covalent bond according to one embodiment of the present invention.
  • a covalent bond is not a bond in which an atom unilaterally gives electrons to another atom, but a bond that is formed when two atoms release electrons from each other to form an electron pair and share it.
  • a bond that is electrically neutral and shares electrons to form a stable electron configuration is called a covalent bond.
  • Example 1 In order to prove the superiority and reliability of a composition for treating and preventing rhinitis according to one embodiment of the present invention, the therapeutic effect was measured through Example 1.
  • Table 1 is a clinical trial to measure the extent of the therapeutic effect on rhinitis by administering a composition (containing germanium (Ge), iron (Fe), strontium (Sr), calcium (Ca), copper (Cu), manganese (Mn), magnesium (Mg), zinc (Zn), potassium (K), silicon (Si), and sodium (Na) as active ingredients, each of which has lost at least one electron) according to one embodiment of the present invention.
  • a total of 34 patients were targeted, including 14 patients with allergic rhinitis, 3 patients with chronic sinusitis, 6 patients with seasonal allergic rhinitis, 5 patients with acute sinusitis, 3 patients with dry rhinitis, 1 patient with nasal cancer, and 2 patients with simple rhinitis.
  • Type of patient Number of patients Days of use 90 days 120 days 180 days allergy rhinitis patient 14 people 9 people recovered, 70% recovery, 3 people, 50% heal 2 people 9 people completely cured (no relapse), 3 people 95% cured, 80% heal 2 people 9 people cured (no relapse), 4 new recoveries, 90% recovery rate 1 person Chronic Patient with sinusitis 3 people Treatment effect 10 ⁇ 20% 3 people Treatment effect 30% 1 person, Treatment effect 25% 2 people Treatment effect 35% 1 person, Treatment effect 30% 2 people Seasonality allergy rhinitis patient 6 people 5 people recovered more than 70%, 1 person fully recovered 6 people cured No recurrence Acute Patient with sinusitis 5 people 50% recovery 2 people, 20 ⁇ 25% healing for 3 people 80% recovery rate 1 person, 60% recovery 1 person, 35 ⁇ 45% heal 3 people 1 person cured, 2 people recovered over 60%, 2 people cured over 50% Dry rhinitis 3 people 3 people cured No recurrence.
  • Example 1 of this composition which does not contain any existing pharmaceutical ingredients including steroids, clearly demonstrate that this composition is a technological treatment for rhinitis and nasal diseases.
  • the active ingredients of the composition may include at least one of a nutrient, a hardener, a solubilizer, an oil, a preservative, a thickener, a refreshing agent, or a fragrance.
  • the composition is excellent in treating rhinitis in animals (including mammals, livestock such as pigs, cows, horses, and pets) and in treating and preventing various nasal diseases, since its principles are the same as those for humans. Therefore, it can be used as a nasal disease treatment agent for livestock and pets.
  • this composition is a treatment for rhinitis and various nasal diseases that is made by combining only the nutrients essential to the human body, without any chemical or harmful ingredients including steroids or antibiotics, so it is the world's first treatment with absolutely no side effects, even if overused or abused. In addition, it is the world's first and only rhinitis treatment that has never been seen in human history.
  • treatment Modern medicine that does this is called treatment, but this is nonsense.
  • the meaning of treatment is clearly stated in the dictionary as "to manage a disease or wound well and cure it.” It may be an illegal act to call treatment something that worsens rhinitis and makes it impossible to smell, rather than cure it.
  • steroid-containing medication is used to temporarily relieve only the symptoms of rhinitis.
  • the problem here is that if you use medication containing steroids, not only will it make it impossible to cure rhinitis due to the side effects of the steroids, but it will also worsen rhinitis, ultimately making you unable to smell. For this reason, except for patients whose rhinitis is so severe that they want to die, steroid-containing medication is never used, no matter how severe the rhinitis is.
  • the inventor of this invention seeks to solve the suffering of rhinitis by uncovering the cause of rhinitis, a painful disease that causes 20,000 out of 100,000 severe rhinitis patients to lose their sense of smell. After more than 10 years of research, the inventor of this invention has discovered that the cause of rhinitis is various toxic substances accumulated in nasal cells.
  • this composition is a rhinitis cure that does not contain any chemical ingredients including steroids or antibiotics, and only combines the nutrients necessary for the human body. Therefore, there is no limit to the daily usage, and the more frequently it is administered, the more the cause of rhinitis is removed, and the faster the rhinitis cure is achieved. And, there is no special limitation on the administration period, and the more it is administered, the better the therapeutic effect.
  • the composition for treating and preventing rhinitis of the present invention is the world's only revolutionary rhinitis cure mechanism that completely cures rhinitis by pulling out the root of the cause of rhinitis in a short period of time without any side effects, so that the existing rhinitis treatment mechanisms will be discarded or become useless.
  • this composition is effective not only in curing rhinitis but also in relieving various nasal diseases, it can be very useful for any nasal disease, except bacterial nasal disease.

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne une composition pour le traitement et la prévention de la rhinite, contenant, en tant qu'ingrédients actifs, au moins cinq types de minéraux parmi le germanium (Ge), l'argent (Ag), l'iridium (Ir), le nickel (Ni), le palladium (Pd), le tantale (Ta), l'antimoine (Sb), le zinc (Zn), l'indium (In), le bore (B), l'astatine (At), le thallium (Tl), le carbonate de magnésium (MgCO3), l'étain (Sn), le fer (Fe), le sulfure de calcium (CaS), le molybdène (Mo), le chrome (Cr), le sodium (Na), le tungstène (W), le gallium (Ga), le strontium (Sr), le potassium (K), le béryllium (Be), le baryum (Ba), le magnésium (Mg), le scandium (Sc), l'yttrium (Y), le calcium (Ca), le titane (Ti), le vanadium (V), l'hafnium (Hf), le brome (Br), le zirconium (Zr), le cuivre (Cu), le manganèse (Mn), le rubidium (Rb), le technétium (Tc), le platine (Pt), le niobium (Nb), l'or (Au), le phosphate (Pi), le rhénium (Re), le ruthénium (Ru), le cobalt (Co), l'oxyde de zinc (ZnO), l'aluminium (Al), le sélénium (Se), le bismuth (Bi), le phosphore (P), le rhodium (Rh), le silicium (Si), l'iode (I), le tellure (Te), le soufre (S), le lithium (Li), l'osmium (Os), l'hydroxyde de magnésium (Mg(OH)2), et le césium (Cs), chacun des minéraux ayant perdu au moins un électron. La composition est très sûre pour le corps humain et peut ainsi être hautement efficace dans le traitement de la rhinite mais peut également être utilisée de manière très avantageuse en tant qu'agent de traitement et de prévention pour diverses affections nasales.
PCT/KR2024/096263 2023-10-10 2024-10-10 Composition pour le traitement et la prévention de la rhinite et son procédé de préparation Pending WO2025080075A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2023-0134377 2023-10-10
KR1020230134377A KR20250051353A (ko) 2023-10-10 2023-10-10 비염의 치료와 예방용 조성물 및 그 제조방법

Publications (1)

Publication Number Publication Date
WO2025080075A1 true WO2025080075A1 (fr) 2025-04-17

Family

ID=95396071

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2024/096263 Pending WO2025080075A1 (fr) 2023-10-10 2024-10-10 Composition pour le traitement et la prévention de la rhinite et son procédé de préparation

Country Status (2)

Country Link
KR (1) KR20250051353A (fr)
WO (1) WO2025080075A1 (fr)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000017999A (ko) * 2000-01-03 2000-04-06 오순근 산호석회암의 이온화 제조법
WO2009096737A2 (fr) * 2008-01-31 2009-08-06 Chung-Ang University Industry-Academy Cooperation Foundation Nouveaux composés de germanium organiques et compositions comprenant ceux-ci comme principes actifs
KR20090107261A (ko) * 2008-04-08 2009-10-13 김천균 미네랄 함유수의 제조방법 및 이에 의해 제조된 미네랄함유수
KR20110028150A (ko) * 2009-09-11 2011-03-17 김달수 게르마늄, 맥반석 및 홍삼 추출물을 함유하는 알레르기성 비염의 예방 및 치료용 건강식품조성물
KR20210002895A (ko) * 2019-07-01 2021-01-11 김천균 시린 이 및 치주질환 방지용 치약 및 그 제조방법
JP2021504325A (ja) * 2017-11-23 2021-02-15 アファビオ セラピティックスＡｐｈａｂｉｏ Ｔｈｅｒａｐｅｕｔｉｃｓ 鼻副鼻腔炎を治療するためのケルセチンベースの組成物
KR102343912B1 (ko) * 2021-03-19 2021-12-28 경상국립대학교산학협력단 복합 이온미네랄 용액을 유효성분으로 함유하는 항암 또는 항염증 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210150829A (ko) 2020-06-04 2021-12-13 경성대학교 산학협력단 참당귀 추출물 및 인디루빈 농축물을 포함하는 건선 또는 비염치료용 조성물

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000017999A (ko) * 2000-01-03 2000-04-06 오순근 산호석회암의 이온화 제조법
WO2009096737A2 (fr) * 2008-01-31 2009-08-06 Chung-Ang University Industry-Academy Cooperation Foundation Nouveaux composés de germanium organiques et compositions comprenant ceux-ci comme principes actifs
KR20090107261A (ko) * 2008-04-08 2009-10-13 김천균 미네랄 함유수의 제조방법 및 이에 의해 제조된 미네랄함유수
KR20110028150A (ko) * 2009-09-11 2011-03-17 김달수 게르마늄, 맥반석 및 홍삼 추출물을 함유하는 알레르기성 비염의 예방 및 치료용 건강식품조성물
JP2021504325A (ja) * 2017-11-23 2021-02-15 アファビオ セラピティックスＡｐｈａｂｉｏ Ｔｈｅｒａｐｅｕｔｉｃｓ 鼻副鼻腔炎を治療するためのケルセチンベースの組成物
KR20210002895A (ko) * 2019-07-01 2021-01-11 김천균 시린 이 및 치주질환 방지용 치약 및 그 제조방법
KR102343912B1 (ko) * 2021-03-19 2021-12-28 경상국립대학교산학협력단 복합 이온미네랄 용액을 유효성분으로 함유하는 항암 또는 항염증 조성물

Also Published As

Publication number Publication date
KR20250051353A (ko) 2025-04-17

Similar Documents

Publication Publication Date Title
Jarald et al. Antioxidant and antimicrobial activities of cow urine
CN1113599C (zh) 单纯性疱疹病毒和其它感染性疾病的抗微生物疗法
CN1121232C (zh) 治疗疱疹的药物组合物
US20180064775A1 (en) Anti-pathogenic compositions
DE60018200T2 (de) Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen
WO2025080075A1 (fr) Composition pour le traitement et la prévention de la rhinite et son procédé de préparation
KR101148446B1 (ko) 당질코르티코스테로이드를 가열멸균시키는 방법
Cheng et al. Efficacy of different irrigation solutions on the early debridement of open fracture in rats
CN103828841B (zh) 一种防治家蚕微粒子病的药物组合物及其应用
EP3349741A1 (fr) Composition à effet antiviral
WO2025014333A1 (fr) Composition pour le traitement et la prévention de l'asthme, et sa méthode de fabrication
DE102005053926B3 (de) Verwendung eines antibakteriellen Mittels aus einer Mischung aus Pflanzendrogen oder Extrakten daraus
WO2012011675A2 (fr) Additif alimentaire comprenant un minéral silicaté fermenté spécialement pour remplacer les antibiotiques, pour réguler la fonction immunitaire et promouvoir la croissance chez les animaux, et procédé de production de celui-ci
WO2025005662A2 (fr) Composition de gouttes oculaires pour le traitement et la prévention de maladies oculaires et son procédé de préparation
CN103202881A (zh) 一种治疗皮疹的外用剂组合物
KR20240016954A (ko) 분별된 꿀을 사용한 병태 치료용 조성물 및 방법
CN1279939C (zh) 一种治疗鼻炎的药物喷剂
CN102008586A (zh) 一种治疗皮肤病的特效药物
KR20250010486A (ko) 천식의 치료와 예방용 조성물 및 그 제조방법
CN120754185A (zh) 一种兽用治疗外伤的中药粉剂
Rawat et al. Impact of sanitizer on normal human microflora: A review on effect of frequent use of sanitizer on normal human microflora
US20230241126A1 (en) Compositions and methods for disruption of biofilms using fractionated honey
KR20250017610A (ko) 아토피의 치료와 예방용 조성물 및 그 제조방법
CN106727981B (zh) 一种杀灭畜禽体外寄生虫的中药组合物及其制备方法和应用
Jawed et al. Preventive Effect of Turmeric against Anti-Mosquito Smoke Induced Pulmonary Fibrosis in Laboratory Rat

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24877610

Country of ref document: EP

Kind code of ref document: A1